Maternal profiles and outcome of Placenta Accreta Spectrum (PAS) in a retrospective cohort study in Dr. Saiful Anwar General Hospital, Malang, Indonesia
Downloads
HIGHLIGHTS
- This study compares maternal characteristics and outcomes between PAS and non-PAS patients, including analysis using the Placenta Accreta Index.
- PAS is associated with significantly higher intraoperative blood loss and postoperative ICU admission rates.
- Findings underscore the importance of early identification and PAI-based risk stratification to optimize surgical planning and maternal outcomes.
ABSTRACT
Objective: This study aims to investigate maternal risk factors associated with PAS among patients at Dr. Saiful Anwar Regional General Hospital in Malang.
Materials and Methods: This retrospective cohort study was conducted at RSUD Dr. Saiful Anwar Malang, analyzing medical records of patients diagnosed with Placenta Accreta Spectrum (PAS) from January 2023 to August 2024. Patients were categorized into PAS and non-PAS groups, with further classification of PAS patients based on their Placenta Accreta Index (PAI) score (<5 and ≥5) to compare clinical outcomes. A total of 47 eligible patients were included based on gestational age ≥28 weeks, clinical suspicion of PAS, and histopathological confirmation. Demographic, clinical, intraoperative, and postoperative data were collected and analyzed. Data were analyzed using SPSS 27.0. Ethical approval was obtained from the RSUD Dr. Saiful Anwar Ethics Committee.
Results: Patients with PAI scores ≥5 had higher intraoperative blood loss (3467.50 ± 2520.35 mL) compared to those with PAI scores <5 (2212.50 ± 1055.32 mL, p=0.764). Hysterectomy was the primary surgical approach in both groups (PAI <5: 88.88%, PAI <5: 92.75%, p=0.667). Bladder trauma (AAST grade IV) occurred in 100% of patients with PAI <5, whereas bladder infiltration was observed only in the PAI ≥5 group (p=0.117). NICU admission was more frequent in the PAI ≥5 group (31.25% vs. 0%, p=0.061). ICU admission was required in all PAI <5 patients (100%) and 75% of PAI <5 patients (p=0.102). No statistically significant associations were found.
Conclusion: Higher PAI score may indicate a more complex clinical course, further research with larger sample sizes is necessary to validate its predictive value.
Markfeld Erol F, Häußler JA, Medl M, et al. Placenta Accreta Spectrum (PAS): Diagnosis, Clinical Presentation, Therapeutic Approaches, and Clinical Outcomes. Medicina (B Aires) 2024; 60: 1180.
Bartels HC, Postle JD, Downey P, et al. Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers. Dis Markers 2018; 2018: 1–11.
Pegu B, Thiagaraju C, Nayak D, et al. Placenta accreta spectrum-a catastrophic situation in obstetrics. Obstet Gynecol Sci 2021; 64: 239–247.
CARUSI DA. The Placenta Accreta Spectrum: Epidemiology and Risk Factors. Clin Obstet Gynecol 2018; 61: 733–742.
Jauniaux E, Hussein AM, Fox KA, et al. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol 2019; 61: 75–88.
Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study. PLoS One 2012; 7: e52893.
Rac MWF, Dashe JS, Wells CE, et al. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol 2015; 212: 343.e1-343.e7.
Morlando M, Sarno L, Napolitano R, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand 2013; 92: 457–460.
Kharisma Y, Agustina H, Suryanti S, et al. Maternal Characteristics and Histopathological Features of Placenta Accreta Spectrum in Dr. Hasan Sadikin General Hospital Bandung, Period 2015–2020. Althea Medical Journal 2022; 9: 55–60.
Ornaghi S, Maraschini A, Donati S. Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: A prospective population-based cohort study. PLoS One 2021; 16: e0252654.
Farquhar CM, Li Z, Lensen S, et al. Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: a case–control study. BMJ Open 2017; 7: e017713.
Koo Y-J, Ryu H-M, Yang J-H, et al. Pregnancy outcomes according to increasing maternal age. Taiwan J Obstet Gynecol 2012; 51: 60–65.
Garmi G, Salim R. Epidemiology, Etiology, Diagnosis, and Management of Placenta Accreta. Obstet Gynecol Int 2012; 2012: 1–7.
Jenabi E, Najafi-Vosough R, Nazari A. Obesity and risk of placenta accreta spectrum: A meta-analysis. Open Medicine; 19. Epub ahead of print 18 October 2024. DOI: 10.1515/med-2024-1047.
Ferrari FA, Garzon S, Raffaelli R, et al. Tranexamic acid for the prevention and the treatment of primary postpartum haemorrhage: a systematic review. J Obstet Gynaecol (Lahore) 2022; 42: 734–746.
Melber DJ, Berman ZT, Jacobs MB, et al. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol. Am J Obstet Gynecol 2021; 225: 442.e1-442.e10.
Elbery SA, Mahmoud MA, Mansour AE, et al. Incidence and Risk Factors of Morbidely Adherent Placenta in Cases with Previous Caesarean Section in Benha University Hospital. Benha Journal of Applied Sciences 2020; 5: 1–6.
Kayem G, Seco A, Vendittelli F, et al. Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study. Sci Rep 2024; 14: 6564.
Varlas VN, Bors RG, Birsanu S, et al. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center. J Med Life 2021; 14: 367–375.
Fournier SB, D’Errico JN, Stapleton PA. Uterine Vascular Control Preconception and During Pregnancy. In: Comprehensive Physiology. Wiley, 2021, pp. 1871–1893.
James-Allan LB, Whitley GS, Leslie K, et al. Decidual cell regulation of trophoblast is altered in pregnancies at risk of pre-eclampsia. J Mol Endocrinol 2018; 60: 239–246.
Yeni CM, Andayani H, Indirayani I, et al. The Association betweeen Cesarean Section and Placenta Accreta Hubungan antara Seksio Sesarea dan Plasenta Akreta. Indones J Obstet Gynecol.
Kietpeerakool C, Lumbiganon P, Laopaiboon M, et al. Pregnancy outcomes of women with previous caesarean sections: Secondary analysis of World Health Organization Multicountry Survey on Maternal and Newborn Health. Sci Rep 2019; 9: 9748.
Cahill AG, Beigi R, Heine RP, et al. Placenta Accreta Spectrum. Am J Obstet Gynecol 2018; 219: B2–B16.
Basilio E, Chen R, Fernandez AC, et al. Wildfire Smoke Exposure during Pregnancy: A Review of Potential Mechanisms of Placental Toxicity, Impact on Obstetric Outcomes, and Strategies to Reduce Exposure. Int J Environ Res Public Health 2022; 19: 13727.
Gandley RE, Jeyabalan A, Desai K, et al. Cigarette exposure induces changes in maternal vascular function in a pregnant mouse model. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2010; 298: R1249–R1256.
Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Practice and Research: Clinical Obstetrics and Gynaecology 2021; 72: 84–91.
Copyright (c) 2025 Bambang Rahardjo, Harry Dwi Pratama, Rosalia Purbandari, Fathi Nabila Alim
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
